{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":2,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":29,"n_cols":5,"rows_kept":29,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[10,2,10,3],[10,4,10,5],[11,2,11,3],[11,4,11,5],[12,2,12,3],[14,2,14,3],[15,2,15,3],[16,2,16,3],[17,2,17,3],[20,2,20,3],[21,2,21,3],[25,2,25,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNIORUON00487369"]
[null,null,"Autore",null,"ČUKOVSKAJA, Lidija K."]
[null,null,"Titolo",null,"Pamjati Anny Achmatovoj : stichi, pis'ma ; Zapiski ob Anne Ahmatovoj / L. Čukovskaja"]
[null,null,"Pubbl/distr/stampa",null,"Paris, : YMCA-Press, 1974"]
[null,null,"Descrizione fisica",null,"220 p. : tav. ; 19 cm."]
[null,null,"Disciplina",null,"891.704"]
[null,null,"Soggetti",null,"ACHMATOVA ANNA ANDREEVNA"]
[null,null,"Lingua di pubblicazione",null,"Russo"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,"2.","Record Nr.",null,"UNINA9910985685403321"]
[null,null,"Titolo",null,"Marcus and Feldman's osteoporosis / / edited by David W. Dempster, Jane A. Cauley, Mary L. Bouxsein, Felicia Cosman"]
[null,null,"Pubbl/distr/stampa",null,"London, United Kingdom : , : Elsevier/Academic Press, , [2021]"]
[{"$nulls":4},"©2021"]
[null,null,"ISBN",null,"0-12-813073-3"]
[null,null,"Edizione",null,"[Fifth edition.]"]
[null,null,"Descrizione fisica",null,"1 online resource (2 volumes) : illustrations"]
[null,null,"Soggetti",null,"Osteoporosis"]
[{"$nulls":4},"Fractures, Bone - pathology"]
[{"$nulls":4},"Osteoporosis - therapy"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Revised edition of: Osteoporosis / edited by Robert Marcus, David Feldman, David W. Dempster, Marjorie Luckey, Jane A. Cauley. Fourth edition. 2013."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references."]
[null,null,"Nota di contenuto",null,"-- Volume 1. Part I. Introduction. The nature of osteoporosis  -- The bone organ system: form and function -- Part II. Developmental, cellular and molecular biology of bone. Development of the skeleton -- The skeletal stem cell -- Osteoclast biology -- Osteoblast biology: developmental origin and interactive nature of osteoblasts -- Osteocytes -- The regulatory role of matrix proteins in mineralization of bone -- Part III. Skeletal hormones and regulatory factors. Parathyroid hormone and parathyroid hormone-related protein -- Phosphatonins -- Skeletal growth factors -- WNT signaling in skeletal homeostasis and diseases -- Part IV. Biomechanics and mechanobiology. The mechanical behavior of bone -- Cellular and molecular mechanotransduction in bone -- Adaptation of skeletal structure to mechanical loading -- Biomechanics of hip and vertebral fractures -- Part V. Epidemiology of osteoporosis. Epidemiologic methods in studies of osteoporosis -- Genetics of osteoporosis -- Race, ethnicity, and osteoporosis -- Geographic variability in the incidence of hip and vertebral fractures -- Nutrition and osteoporosis -- Physical activity, exercise and skeletal health -- Reproductive and hormonal factors and the risk for osteoporosis -- Clinical and epidemiological studies: skeletal changes across menopause -- Osteoporosis in men: what is similar and what is different? -- Falls as risk factors for fracture -- Impact of physical characteristics and "]
[{"$nulls":4},"lifestyle factors on bone density and fractures -- Imminent fracture risk and disability post fracture -- Economics of osteopososis -- Part VI. General pathophysiology of osteoporosis. Skeletal heterogeneity and the purposes of bone remodeling -- On the evolution and contemporary roles of bone remodeling -- Estrogen deficiency and the pathogenesis of osteoporosis -- Cytokines and the pathogenesis of osteoporosis -- Bone and fat -- Bone, muscle, and sarcopenia -- Bone mineral acquisition in utero and during infancy and childhood -- Osteoporosis in childhood and adolescence -- Osteoporosis in premenopausal women, pregnancy, and lactation -- Bone and the microbiome -- Volume 2. Part VII. Impact of comorbidity and medications on skeletal health. Immobilization osteoporosis -- Osteoporosis in neurological disorders: Parkinson's disease, stroke, and multiple sclerosis -- Effects on the skeleton from medications used to treat non-skeletal disorders -- Osteoporosis associated with gastrointestinal disorders; celiac and inflammatory bowel diseases -- Osteoporosis associated with eating disorders -- Glucocorticoid-induced osteoporosis and Cushing's syndrome -- Thyroid hormone, thyroid medication, and the skeleton -- The skeletal actions of parathyroid hormone in primary hyperparathyroidism -- Osteogenesis imperfecta and other defects of bone development as occasional causes of adult osteoporosis -- Human immunodeficiency virus and osteoporosis -- Diabetes, diabetic medications, and risk of fracture -- Skeletal health after bariatric surgery -- Osteoporosis in organ transplant patients -- Osteoporosis associated with rheumatologic disorders -- Osteoporosis associated with chronic kidney disease -- Relationship between periodontal disease, tooth loss and osteoporosis -- Impact of breast cancer and its treatment on bone loss and fracture risk - pathophysiology and management -- Management of bone health in men with prostate cancer -- Impact of MGUS and myeloma on skeletal health -- Renal stone disease, hypercalciuria and osteoporosis: use of thiazides and alkali for osteoporosis -- Sleep disorders and osteoporosis -- Part VIII. Diagnosis and evaluation. Evaluation of the osteoporosis patient -- Who should be screened for osteoporosis? -- Vertebral fracture identification -- Noninvasive imaging techniques and fracture risk assessment -- Biochemical markers of bone turnover in osteoporosis -- A comparison of fracture risk assessment tools -- Part IX. Patient management. Orthopedic aspects of osteoporosis -- Fall prevention interventions -- Exercise and other physical therapy interventions in the management of osteoporosis -- Calcium and vitamin d in the management of osteoporosis -- Nutrients beyond calcium and vitamin d to treat osteoporosis -- Condition still critical: compliance and persistence with osteoporosis medications -- Part X. Pharmacotherapeutics. Estrogen and estrogen analogs for prevention and treatment of osteoporosis -- Bisphosphonates pharmacology and use in the treatment of osteoporosis -- Denosumab for the treatment of osteoporosis -- Teriparatide and abaloparatide treatment for osteoporosis -- Calcitonin in osteoporosis -- Androgens -- Long-term bisphosphonate treatment: continuation and interruption -- Romosozumab in the treatment of postmenopausal osteoporosis -- Lessons from bone histomorphometry on the mechanisms of action of osteoporosis drugs -- Part XI. New directions. Long term treatment strategies and goal directed therapy."]
[null,null,null,"Sommario/riassunto","Marcus and Feldman's Osteoporosis, Fifth Edition, is the most comprehensive, authoritative reference on this disease. Led by a new editorial team, this fifth edition offers critical information on reproductive and hormonal risk factors, new therapeutics, ethnicity, nutrition, therapeutics, management and economics, comprising a "]
[{"$nulls":4},"tremendous wealth of knowledge in a single source not found elsewhere. Written by renowned experts in the field, this two-volume reference is a must-have for biomedical researchers, research clinicians, fellows, academic and medical libraries, and any company involved in osteoporosis drug research and development."]